XBIO-020

N/A

Report date: 2025/06/25 11:49:02

Base Information

Drug NameXBIO-020

Drug Alias NameDNase I-Armored CAR TXBIO-020

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionDeoxyribonuclease 1 modulatorsNeutrophil Extracellular Traps scavengers

TargetsDeoxyribonuclease 1Neutrophil Extracellular Traps

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesXenetic Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesXenetic Biosciences Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A